与模型对照组比较，山药合剂两剂量组血清谷丙转氨酶、谷草转氨酶和肝组织乳酸脱氢酶活性及血清葡萄糖、三酰甘油、游离脂肪酸和肝组织丙二醛含量显著降低（P<0.05～0.01）；
Compared with model control group, ALT, AST, Glu, TG, FFA in serum, and LDH activity and MDA content in liver tissues were markedly reduced in two Shanyao mixture groups (P < 0.05-0.01).
抑制脂肪代谢相关酶脂蛋白脂酶、硬脂酰辅酶A 脱氢酶、脂肪酸合成酶等的活性来产生降脂作用。
CLA may inhibit the enzymes, lipoprotein lipase(LPL), stearoyl-CoA desaturase(SCD), fatty acid synthase(FAS)and so on, which are related to lipid metabolism.
抑制脂肪代谢相关酶脂蛋白脂酶、硬脂酰辅酶A 脱氢酶、脂肪酸合成酶等的活性来产生降脂作用。
CLA may inhibit the enzymes, lipoprotein lipase(LPL), stearoyl-CoA desaturase(SCD), fatty acid synthase(FAS)and so on, which are related to lipid metabolism.
应用推荐